BlackRock, Inc. 13D and 13G filings for Legend Biotech Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-05 12:18 pm Purchase | 2024-03-31 | 13G | Legend Biotech Corporation LEGN | BlackRock Inc. BLK | 10,768,060 3.000% | 235,684 (+2.24%) | Filing |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Legend Biotech Corporation LEGN | BlackRock Inc. BLK | 10,532,376 5.800% | 10,532,376 (New Position) | Filing |